Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

BACKGROUND: The modified Glasgow Prognostic Score (mGPS) is a composite biomarker that uses albumin and C reactive protein (CRP). There are multiple immune checkpoint inhibitor (ICI)-based combinations approved for metastatic renal cell carcinoma (mRCC). We investigated the ability of mGPS to predic...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Immunother Cancer
Main Authors: Brown, Jacqueline T, Liu, Yuan, Shabto, Julie M, Martini, Dylan, Ravindranathan, Deepak, Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Yantorni, Lauren, Joshi, Shreyas Subhash, Kissick, Haydn, Ogan, Kenneth, Nazha, Bassel, Carthon, Bradley C, Kucuk, Omer, Harris, Wayne B, Master, Viraj A, Bilen, Mehmet Asim
פורמט: Artigo
שפה:Inglês
יצא לאור: BMJ Publishing Group 2021
נושאים:
Immunotherapy Biomarkers
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC8323383/
https://ncbi.nlm.nih.gov/pubmed/34326170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-002851
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים